Department of Dentistry, School of Dentistry, National Yang-Ming University, Taipei, Taiwan.
J Oral Pathol Med. 2011 May;40(5):397-404. doi: 10.1111/j.1600-0714.2010.01003.x. Epub 2011 Jan 19.
Oral squamous cell carcinoma (OSCC) is an important malignant disease around the world. Aberrant expression of MicroRNAs (miRNAs) has been implicated in carcinogenesis of various cancers. In previous studies, up-regulation of miR-181 was observed when OSCC progressed from leukoplakia, dysplasia to invasive carcinoma. However, the function of miR-181 in oral tumorigenesis remains unclear.
The expression levels of miR-181 in the tissue and plasma of OSCC patients were measured by quantitative RT-PCR. The correlation between miR-181 level and multiple clinical variables were then checked by Mann-Whitney test and Wilcoxon matched pairs test. To study the functional meaning of up-regulated miR-181, migration assay and invasion assay by transwells and colony forming assay were applied to analyze the tumorigenic phenotypes of OSCC cells with ectopical expression of miR-181.
Among different clinical variables, over-expression of miR-181 was correlated with lymph-node metastasis, vascular invasion, and a poor survival. Functional assays revealed ectopically over-expressed miR-181 would enhance cell migration and invasion, but not the ability of anchorage-independent growth of OSCC cells. In addition, the up-regulation of miR-181 could be detected both in tumor tissues and plasma.
miR-181 may enhance lymph-node metastasis through regulating migration, which could potentially be exploited as a putative biomarker for patients with OSCC.
口腔鳞状细胞癌(OSCC)是全球范围内一种重要的恶性疾病。微小 RNA(miRNA)的异常表达与多种癌症的发生有关。在之前的研究中,观察到 miR-181 在 OSCC 从白斑病、发育不良到浸润性癌的进展过程中上调。然而,miR-181 在口腔肿瘤发生中的功能仍不清楚。
通过定量 RT-PCR 测量 OSCC 患者组织和血浆中 miR-181 的表达水平。然后通过 Mann-Whitney 检验和 Wilcoxon 配对检验检查 miR-181 水平与多个临床变量之间的相关性。为了研究上调的 miR-181 的功能意义,通过 Transwell 进行迁移和侵袭实验以及集落形成实验,分析外源性表达 miR-181 的 OSCC 细胞的致瘤表型。
在不同的临床变量中,miR-181 的过表达与淋巴结转移、血管浸润和不良生存相关。功能实验表明,外源性过表达 miR-181 可增强 OSCC 细胞的迁移和侵袭能力,但不增强其锚定非依赖性生长能力。此外,miR-181 的上调可在肿瘤组织和血浆中检测到。
miR-181 可能通过调节迁移增强淋巴结转移,这可能被用作 OSCC 患者的潜在生物标志物。